Ovensa Announces Collaboration with Takeda

Ontario Industry Updates
Written By Guest User

Ovensa announced a collaboration agreement with Takeda Pharmaceutical Company Limited to evaluate TRIOZAN™, Ovensa's proprietary nanomedicine platform.

Click here to learn more

Guest User
Previous

MIMOSA CEO Profiled in Women of Influence
Next

Synaptive Medical Appoints CFO